Several neurotransmitters, in particular serotonin (5-HT), have demonstrated multiple functions during early development and mid-gestational craniofacial morphogenesis. Early studies indicated that 5-HT is present in the oocyte, where it appears to function as a regulator of cell cleavage. Later, it has a significant role during gastrulation, during which there are significant areas of 5-HT uptake in the primitive streak. Subsequently, in association with neurulation, 5-HT uptake is seen in the floor plate of the developing neural tube. During neural crest formation and branchial arch formation, 5-HT has been demonstrated to facilitate cell migration and stimulate cell differentiation. During morphogenesis of the craniofacial structures, 5-HT stimulates dental development and may aid in cusp formation. All of the most commonly prescribed anti-depressant drugs inhibit serotonin uptake, yet they do not appear to cause major craniofacial malformations in vivo. Given the wide spectrum of effects that 5-HT has during development, it is difficult to understand why these anti-depressants are not major teratogens. Redundancy within the system may allow receptor and uptake pathways to function normally even with lower than normal levels of circulating serotonin. Serotonin-binding proteins, that are expressed in most craniofacial regions at critical times during craniofacial development, may have a buffering capacity that maintains adequate 5-HT tissue concentrations over a wide range of 5-HT serum concentrations. Dental development appears to be particularly sensitive to even small fluctuations in concentrations of 5-HT. Therefore, it may be that children of patients who have received selective serotonergic re-uptake inhibitors (such as Prozac and Zoloft) or the less selective tricyclic anti-depressant drugs (such as Elavil) would be at a higher risk for developmental dental defects such as anodontia and hypodontia. In this review, the evidence supporting a role for 5-HT during mammalian craniofacial development is discussed. A series of models is proposed that may explain how the craniofacial effects of 5-HT are mediated.
References
1.
Aberg T., Wozney J., Thesleff I. (1997). Expression patterns of bone morphogenetic proteins (Bmps) in the developing mouse tooth suggest roles in morphogenesis and cell differentiation. Dev Dyn210:383-396.
2.
Agrez MV, Ames MM, Lieber MM, Tyce GM ( 1984). The presence of serotonin in animal sera used in cell culture. Biogenic Amines1:223-228.
3.
Blakely RD, Berson HE, Fremeau RT, Caron MG, Peek MM, Prince HK, et al. (1991). Cloning and expression of a functional serotonin transporter from rat brain. Nature354:66-70.
4.
Burden RW, Lawrence IE (1973). Presence of biogenic amines in early rat development. Am I Anat136:251-257.
5.
Burridge K., Chrzanowska-Wodnicka M. (1996). Focal adhesions, contractility, and signaling. Ann Rev Cell Dev Biol12:463-519.
6.
Burridge K., Turner CE, Romer LH (1992). Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol119:893-903.
7.
Buznikov GA (1991). The biogenic amines as regulators of early (pre-nervous) embryogenesis: new data. Adv Exp Med Biol296:33-48.
8.
Buznikov GA, Chadakova IV, Zvegdiva ND (1964). The role of neurohumours in early embryogenesis. I. Serotonin in control of developing embryos of sea urchin and loach. J Embryol Exp Morphol12:563-573.
9.
Buznikov GA, Shmukler YB, Lauder JM (1996). From oocyte to neuron: do neurotransmitters function in the same way throughout development? Cell Mol Neurobiol16:533-559.
10.
Chai Y., Mah A., Crohin C., Groff S., Bringas P., Le T., et al. (1994). Specific transforming growth factor-β subtypes regulate embryonic mouse Meckel's cartilage and tooth development. Dev Biol162:85-103.
11.
Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996). Birth outcomes in pregnant women taking Fluoxetine. N Engl J Med335:1010-1015.
12.
Choi DS, Ward SJ, Messaddeq N., Launay JM, Maroteaux L. (1997). 5-HT receptors-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development124:1745-1755.
13.
Emanuelsson H. (1976). Serotonin in chick embryo cells during early morphogenesis (abstract). J Cell Biol70:131.
14.
Emanuelsson H., Carlberg M., Lowkvist B. (1988). Presence of serotonin in early chick embryos. Cell Diff24:191-200.
15.
Gershon MD, Liu KP, Karpiak SE, Tamir H. (1983). Storage of serotonin in vivo as a complex with serotonin binding protein in central and peripheral serotonergic neurons. I Neurosci3:1901-1911.
16.
Gilbert N. (1998). Signal transduction pathways of bradykinin receptors and serotonin receptors in rat molars during amelogenesis (MS dissertation). Chapel Hill: University of North Carolina.
17.
Gustafson T., Toneby M. (1970). On the role of serotonin and acetylcholine in sea urchin morphogenesis. Exp Cell Res62:102-117.
18.
Hall BK ( 1980). Tissue interactions and the initiation of osteogenesis and chondrogenesis in the neural crest-derived mandibular skeleton of the embryonic mouse as seen in isolated murine and avian tissues. J Embryol Exp Morphol58:251-264.
19.
Hall B., Horstadius S. (1988). The neural crest. London: Oxford University Press, pp. 30-72.
20.
Hannan GN, McAuslan BR (1987). Immobilized serotonin: a novel substrate for cell culture. Exp Cell Res171:153-163.
21.
Hassell JR, Horigan EA (1982). Chondrogenesis: a model developmental system for measuring teratogenesis, carcinogenesis and mutagenesis. Terat Carcin Mut2:325-331.
22.
Hoffman BJ, Mezey E., Brownstein MJ (1991). Cloning of a serotonin transporter affected by antidepressants. Science254:579-580.
23.
Johnson DS, Heinemann SF (1995). Embryonic expression of the 5-HT3 receptor subunit, 5-HT3R-A, in the rat: an in situ hybridization study. Mol Cell Neurosci6:122-138.
24.
Johnston MC, Bronsky PT (1995). Prenatal craniofacial development: new insights on normal and abnormal mechanisms. Crit Rev Oral Biol Med6:368-422.
25.
Jowett AK, Vainio S., Ferguson MW, Sharpe PT, Thesleff I. (1993). Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth. Development117:461-470.
26.
Lauder JM (1988). Neurotransmitters as morphogens. Prog Brain Res73:365-387.
27.
Lauder JM (1993). Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci16:233-240.
28.
Lauder JM, Zimmerman EF (1988). Sites of serotonin uptake in epithelia of the developing mouse palate, oral cavity and face: possible role in morphogenesis. J Craniofac Gen Dev Biol8:265-276.
29.
Lauder JM, Tamir H., Sadler TW (1988). Serotonin and morphogenesis. I. Sites of serotonin uptake and binding protein immunoreactivity in the midgestational mouse embryo. Development102:709-720.
30.
Lauder JM, Moiseiwitsch J., Liu J., Wilkie MB (1994). Serotonin in development and pathophysiology. In: Brain lesions in the newborn. Lou HC, Greisen G, Larsen JF, editors. Alfred Benzon Symposium. Vol. 37. Copenhagen: Munksgaard, pp. 60-72.
31.
Lee SL, Wang WW, Moore BJ, Fanburg O. (1991). Dual effects of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res68:1362-1368.
32.
Maas R., Bei M. (1997). The genetic control of early tooth development. Crit Rev Oral Biol Med8:4-39.
33.
Marden PM, Smith DW, McDonald MJ (1964). Congenital anomalies in the newborn infant, including minor variations. Pediatrics64:358-371.
34.
Moiseiwitsch JRD (1995). Serotonergic regulation of mouse craniofacial development (PhD dissertation). Chapel Hill: University of North Carolina.
Moiseiwitsch JRD, Lauder JM (1996). Stimulation of murine tooth development in organotypic culture by the neurotransmitter serotonin. Arch Oral Biol41:161-165.
37.
Moiseiwitsch JRD, Lauder JM (1997). Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists. Anat Embryol195:71-78.
38.
Moiseiwitsch JRD, Raymond JR, Tamir H., Lauder JM (1998). Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch Oral Biol43:789-800.
39.
Neer EJ ( 1995). Heterotrimeric G proteins: organizers of transmembrane signals. Cell80:249-257.
40.
Nichols DH (1981). Neural crest formation in the head of the mouse embryo as observed using a new histological technique. J Embryol Exp Morphol64:105-120.
41.
Noden DM (1986). Origins and patterning of craniofacial mesenchymal tissues. J Craniofac Genet Dev Biol2:15-31.
42.
Oosterwegel M., Van de Wetering M., Timmermann J., Kruisbeek A., Destree O., Meijlink F., et al. (1993). Differential expression of the HMG box factors TCF-1 and LEF-1. Development118:439-448.
43.
Palen K., Thorneby L., Emanuelsson H. (1979). Effects of serotonin and serotonin antagonists on chick embryogenesis. Roux's Arch Dev Biol187:89-103.
44.
Parks CL, Robinson PS, Sibille E., Shenk T., Toth M. ( 1998). Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA95:10734-10739.
45.
Pastuszak A., Schick-Boschetto B., Zuber C., Feldkamp M., Pinelli M., Sihn S., et al. (1993). Pregnancy outcome following first-trimester exposure to Fluoxetine (Prozac). J Am Med Assoc269:2246-2248.
46.
Pienkowski MM (1977). Involvement of biogenic amines in control of development of early mouse embryos (abstract). Anat Rec189:550.
47.
Raymond JR, Kim JL, Beach RE, Tisher CC (1993). Immunohistochemical mapping of the cellular and subcellular distribution of 5-HT1A receptors in rat and human kidney. Am J Physiol33:F490-495.
48.
Rosa F. ( 1994). Medicaid anti-depressant pregnancy exposure outcomes (abstract). Reprod Toxicol8:444.
49.
Sadler TW (1979). Culture of early somite mouse embryos during organogenesis. J Embryol Exp Morphol49:17-25.
50.
Shuey DL (1991). Serotonergic mechanisms in normal and abnormal craniofacial morphogenesis (PhD dissertation). Chapel Hill: University of North Carolina.
51.
Shuey DL, Sadler TW, Lauder JM (1992). Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology46:367-378.
52.
Shuey DL, Sadler TW, Tamir H., Lauder JM (1993). Serotonin and morphogenesis. II. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse. Anat Embryol187:75-85.
53.
Slavkin HC, Bringas P. Jr, Sasano Y., Mayo M. ( 1989). Early embryonic mouse mandibular morphogenesis and cytodifferentiation in serumless, chemically defined medium: a model for studies of autocrine and/or paracrine regulatory factors. J Craniofac Genet Dev Biol9:185-205.
54.
Small DH, Wurtman RJ (1984). Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptomes. Proc Natl Acad Sci USA81:959-963.
55.
Solursh M., Ahrens PB, Reiter RS (1978). A tissue culture analysis of the steps in limb chondrogenesis. In Vitro14:51-61.
56.
Tamir H., Lui K., Hsiung S., Adlersberg M., Gershon MD (1994). Serotonin binding protein: synthesis, secretion and recycling. J Neurochem63:97-107.
57.
Thesleff I., Vaahtokari A., Vainio S., Jowett A. (1996). Mole mechanisms of cell and tissue interaction during early tooth development. Anat Rec245:151-161.
58.
Thomas BL, Tucker AS, Qiu M., Ferguson CA, Hardcastle Z., Rubenstein JLR, et al. (1997). Role of Dlx-1 and Dlx-2 genes in patterning of the murine dentition. Development124:4811-4818.
59.
Wallace JA (1982). Monoamines in the early chick embryo: demonstration of serotonin synthesis and the regional distribution of serotonin-concentrating cells during morphogenesis. Am J Anat165:261-276.
60.
Wallace JA, Petrusz P., Lauder JM (1982). Serotonin immunocytochemistry in the adult and developing rat brain: methodological and pharmacological considerations. Brain Res Bull9:117-129.
61.
Wee EL, Zimmerman EF (1983). Involvement of GABA in palate morphogenesis and its relation to diazepam teratogenesis in two mouse strains. Teratology28:15-22.
62.
Willis K., Hahn GK, Moiseiwitsch JRD (2000), Modulation of serotonin binding protein in mandibular explant culture (abstract). J Dent Res79 (Spec lss):589.
63.
Yavarone MS, Shuey DL, Sadler TW, Lauder JM (1993). Serotonin uptake in the ectoplacental cone and placenta of the mouse. Placenta14:149-161.
